Cover Image

Fluorescence Microscopy: Determination of Meropenem Activity against <i>Klebsiella pneumoniae</i>

The development and implementation of diagnostic methods that allow rapid assessment of antibiotic activity against pathogenic microorganisms is an important step towards antibiotic therapy optimization and increase in the likelihood of successful treatment outcome. To determine whether fluorescence...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kamilla N. Alieva (Author), Maria V. Golikova (Author), Anastasia A. Kuznetsova (Author), Stephen H. Zinner (Author)
Format:	Book
Published:	MDPI AG, 2023-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Meropenem MICs at Standard and High Inocula and Mutant Prevention Concentration Inter-Relations: Comparative Study with Non-Carbapenemase-Producing and OXA-48-, KPC- and NDM-Producing <i>Klebsiella pneumoniae</i>
by: Maria V. Golikova, et al.
Published: (2023)

Predicting the Effects of Carbapenem/Carbapenemase Inhibitor Combinations against KPC-Producing <i>Klebsiella pneumoniae</i> in Time-Kill Experiments: Alternative versus Traditional Approaches to MIC Determination
by: Alla V. Filimonova, et al.
Published: (2021)

Pharmacodynamics of Doripenem Alone and in Combination with Relebactam in an In Vitro Hollow-Fiber Dynamic Model: Emergence of Resistance of Carbapenemase-Producing <i>Klebsiella pneumoniae</i> and the Inoculum Effect
by: Elena N. Strukova, et al.
Published: (2023)

Comparative In Vitro Activity of Ceftazidime-Avibactam, Imipenem-Relebactam, and Meropenem-Vaborbactam against Carbapenem-Resistant Clinical Isolates of <i>Klebsiella pneumoniae</i> and <i>Pseudomonas aeruginosa</i>
by: Anthony Sophonsri, et al.
Published: (2024)

Comparative Meropenem Pharmacodynamics and Emergence of Resistance against Carbapenem-Susceptible Non-Carbapenemase-Producing and Carbapenemase-Producing Enterobacterales: A Pharmacodynamic Study in a Hollow-Fiber Infection Model
by: Maria V. Golikova, et al.
Published: (2023)

In Vitro and In Vivo Synergism of Fosfomycin in Combination with Meropenem or Polymyxin B against KPC-2-Producing <i>Klebsiella pneumoniae</i> Clinical Isolates
by: Aghata Cardoso da Silva Ribeiro, et al.
Published: (2023)

Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing <i>Klebsiella pneumoniae</i> Causing Bloodstream Infections in Northern Italy, 2018
by: Paolo Gaibani, et al.
Published: (2021)

Antibacterial Activity of LCB10-0200 against <i>Klebsiella pneumoniae</i>
by: Sang-Hun Oh, et al.
Published: (2021)

Meropenem plus Ertapenem and Ceftazidime-Avibactam plus Aztreonam for the Treatment of Ventilator Associated Pneumonia Caused by Pan-Drug Resistant <i>Klebsiella pneumonia</i>
by: Konstantinos Mantzarlis, et al.
Published: (2024)

Comparison of in vitro activities of meropenem productions on Klebsiella pneumoniae isolated from hospitalized patients
by: Akhi, Mohammad Taghi, et al.
Published: (2014)

Exogenous glutathione reverses meropenem resistance in carbapenem-resistant Klebsiella pneumoniae
by: Juan Yi, et al.
Published: (2023)

In Vitro Activity of "Old" and "New" Antimicrobials against the <i>Klebsiella pneumoniae</i> Complex
by: Alicja Sękowska
Published: (2024)

Nanostructures for Delivery of Flavonoids with Antibacterial Potential against <i>Klebsiella pneumoniae</i>
by: Hanne Lazla Rafael de Queiroz Macêdo, et al.
Published: (2024)

Fluorescence Lifetime Imaging Microscopy of Porphyrins in <i>Helicobacter pylori</i> Biofilms
by: Antonella Battisti, et al.
Published: (2021)

Clinical Outcomes and Safety of Meropenem-Colistin versus Meropenem-Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021)

Characteristics of Environmental <i>Klebsiella pneumoniae</i> and <i>Klebsiella oxytoca</i> Bacteriophages and Their Therapeutic Applications
by: Beata Weber-Dąbrowska, et al.
Published: (2023)

Infection Sources and <i>Klebsiella pneumoniae</i> Antibiotic Susceptibilities in Endogenous <i>Klebsiella</i> Endophthalmitis
by: Kuan-Jen Chen, et al.
Published: (2022)

Synergistic Activity of Temocillin and Fosfomycin Combination against KPC-Producing <i>Klebsiella pneumoniae</i> Clinical Isolates
by: Venera Costantino, et al.
Published: (2024)

Galactose-Clicked Curcumin-Mediated Reversal of Meropenem Resistance among <i>Klebsiella pneumoniae</i> by Targeting Its Carbapenemases and the AcrAB-TolC Efflux System
by: Shivangi Yadav, et al.
Published: (2021)

In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i>
by: Paraskevi Mantzana, et al.
Published: (2023)

Synergistic Activity of Equol and Meropenem against Carbapenem-Resistant <i>Escherichia coli</i>
by: Hye-Rim Kim, et al.
Published: (2021)

Determination of Mutational Timing of Colistin-Resistance Genes through <i>Klebsiella pneumoniae</i> Evolution
by: Jenna M. Kuhn, et al.
Published: (2023)

Current Positioning against Severe Infections Due to <i>Klebsiella pneumoniae</i> in Hospitalized Adults
by: Pablo Vidal-Cortés, et al.
Published: (2022)

Polyclonal Multidrug ESBL-Producing <i>Klebsiella pneumoniae</i> and Emergence of Susceptible Hypervirulent <i>Klebsiella pneumoniae</i> ST23 Isolates in Mozambique
by: José João Sumbana, et al.
Published: (2023)

High Activity of N-Acetylcysteine in Combination with Beta-Lactams against Carbapenem-Resistant <i>Klebsiella pneumoniae</i> and <i>Acinetobacter baumannii</i>
by: Massimiliano De Angelis, et al.
Published: (2022)

Assessment of In-Vitro Synergy of Fosfomycin with Meropenem, Amikacin and Tigecycline in Whole Genome Sequenced Extended and Pan Drug Resistant <i>Klebsiella Pneumoniae</i>: Exploring A Colistin Sparing Protocol
by: Manawr AL-Quraini, et al.
Published: (2022)

Innovative Insights into In Vitro Activity of Colloidal Platinum Nanoparticles against ESBL-Producing Strains of <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>
by: Damir Vukoja, et al.
Published: (2022)

Evaluation of Aztreonam and Ceftazidime/Avibactam Synergism against <i>Klebsiella pneumoniae</i> by MALDI-TOF MS
by: Camila Mörschbächer Wilhelm, et al.
Published: (2023)

Mitomycin C as an Anti-Persister Strategy against <i>Klebsiella pneumoniae:</i> Toxicity and Synergy Studies
by: Olga Pacios, et al.
Published: (2024)

Antimicrobial Activity of a Lipidated Temporin L Analogue against Carbapenemase-Producing <i>Klebsiella pneumoniae</i> Clinical Isolates
by: Emanuela Roscetto, et al.
Published: (2021)

Effective Treatment against ESBL-Producing <i>Klebsiella pneumoniae</i> through Synergism of the Photodynamic Activity of Re (I) Compounds with Beta-Lactams
by: Iván A. González, et al.
Published: (2021)

Epidemiology and In Vitro Activity of Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam against <i>KPC</i>-Producing <i>K. pneumoniae</i> Collected from Bacteremic Patients, 2018 to 2020
by: Federica Bovo, et al.
Published: (2022)

Meropenem/Vaborbactam Plus Aztreonam as a Possible Treatment Strategy for Bloodstream Infections Caused by Ceftazidime/Avibactam-Resistant <i>Klebsiella pneumoniae</i>: A Retrospective Case Series and Literature Review
by: Alessandra Belati, et al.
Published: (2022)

MPC-Based Prediction of Anti-Mutant Effectiveness of Antibiotic Combinations: In Vitro Model Study with Daptomycin and Gentamicin against <i>Staphylococcus aureus</i>
by: Maria V. Golikova, et al.
Published: (2021)

In Vivo Pharmacodynamics of β-Lactams/Nacubactam against Carbapenem-Resistant and/or Carbapenemase-Producing <i>Enterobacter cloacae</i> and <i>Klebsiella pneumoniae</i> in Murine Pneumonia Model
by: Mao Hagihara, et al.
Published: (2021)

Analysis of Capped Silver Nanoparticles Combined with Imipenem against Different Susceptibility Profiles of <i>Klebsiella pneumoniae</i>
by: Inglid Fontoura, et al.
Published: (2023)

Verification of a Novel Approach to Predicting Effects of Antibiotic Combinations: In Vitro Dynamic Model Study with Daptomycin and Gentamicin against <i>Staphylococcus aureus</i>
by: Maria V. Golikova, et al.
Published: (2020)

In Vitro Activity of Omadacycline and Comparator Antibiotics against Extended-Spectrum Beta-Lactamase-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> Urinary Isolates
by: Tyler J. Stone, et al.
Published: (2023)

Evaluation of In Vitro Activity of Double-Carbapenem Combinations against KPC-2-, OXA-48- and NDM-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>
by: Lisa Allander, et al.
Published: (2022)

Investigation of the Antibacterial Activity and Efflux Pump Inhibitory Effect of <i>Cycas thouarsii</i> R.Br. Extract against <i>Klebsiella pneumoniae</i> Clinical Isolates
by: Walaa A. Negm, et al.
Published: (2021)